Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Merck
McKinsey
Johnson and Johnson
Moodys

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

Drugs in MeSH Category Antimetabolites, Antineoplastic

See Plans and Pricing

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medimmune Oncology NEUTREXIN trimetrexate glucuronate INJECTABLE;INJECTION 020326-002 Jul 31, 1998 DISCN No No   Start Trial   Start Trial   Start Trial
Antares Pharma Inc OTREXUP methotrexate SOLUTION;SUBCUTANEOUS 204824-008 Mar 24, 2016 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Hospira CYTARABINE cytarabine INJECTABLE;INJECTION 075383-001 Nov 22, 1999 AP RX No No   Start Trial   Start Trial   Start Trial
Gland Pharma Ltd FLUOROURACIL fluorouracil INJECTABLE;INJECTION 210123-002 Oct 27, 2017 AP RX No No   Start Trial   Start Trial   Start Trial
Bedford FLUOROURACIL fluorouracil INJECTABLE;INJECTION 089508-001 Jan 26, 1988 DISCN No No   Start Trial   Start Trial   Start Trial
Hoffmann La Roche XELODA capecitabine TABLET;ORAL 020896-001 Apr 30, 1998 AB RX Yes No   Start Trial   Start Trial   Start Trial
Mylan Labs Ltd FLUOROURACIL fluorouracil INJECTABLE;INJECTION 202668-001 Jul 17, 2012 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Boehringer Ingelheim
Colorcon
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.